|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/48 | |
| A61K 47/51 | |||
| C07K 14/745 | |||
| C12N 9/64 |
| (11) | Patento numeris | 2948168 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13712086.1 |
| Europos patento paraiškos padavimo data | 2013-03-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-12-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-07-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/030927 |
| Data | 2013-03-13 |
| (87) | Numeris | WO 2014/116275 |
| Data | 2014-07-31 |
| (30) | Numeris | Data | Šalis |
| 201361756359 P | 2013-01-24 | US |
| (72) |
LU, Genmin, US
SINHA, Uma, US
KARBARZ, Mark, US
PANDEY, Anjali, US
CONLEY, Pamela, B., US
|
| (73) |
Portola Pharmaceuticals, Inc.,
270 E. Grand Avenue, South San Francisco, CA 94080,
US
|
| (54) | INHIBITION OF TISSUE FACTOR PATHWAY INHIBITOR WITH FACTOR XA DERIVATIVES |
| INHIBITION OF TISSUE FACTOR PATHWAY INHIBITOR WITH FACTOR XA DERIVATIVES |